Another study on brain tumor stem cells and glioma cells (A172) proved that melatonin in combination with chemotherapeutic agents influences the hypermethylation of the promoter of the ABCG2/BCRP gene responsible for multidrug resistance and tumor recurrence [178] (Table 1). The gene discussed is ABCG2; the disease is neoplasm.